Tags

Type your tag names separated by a space and hit enter

Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
Circ Arrhythm Electrophysiol. 2020 06; 13(6):e008688.CA

Links

PMC Free PDF

Authors+Show Affiliations

Oren O
Division of Hematology and Oncology, Mayo Clinic, Rochester, MN (O.O.).
Yang EH
Division of Cardiology, Department of Medicine, University of California at Los Angeles (E.H.Y.).
Gluckman TJ
Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St Joseph Health, Portland, OR (T.J.G.).
Michos ED
The Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD (E.D.M., R.S.B.).
Blumenthal RS
The Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD (E.D.M., R.S.B.).
Gersh BJ
Department of Cardiovascular Medicine, Mayo Clinic & Mayo Clinic College of Medicine, Rochester, MN (B.J.G.).

MeSH

AntimalarialsBetacoronavirusCOVID-19Cardiovascular DiseasesChloroquineCoronavirus InfectionsGlobal HealthHumansHydroxychloroquineIncidencePandemicsPneumonia, ViralRisk FactorsSARS-CoV-2

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32436730

Citation

Oren, Ohad, et al. "Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials." Circulation. Arrhythmia and Electrophysiology, vol. 13, no. 6, 2020, pp. e008688.
Oren O, Yang EH, Gluckman TJ, et al. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. Circ Arrhythm Electrophysiol. 2020;13(6):e008688.
Oren, O., Yang, E. H., Gluckman, T. J., Michos, E. D., Blumenthal, R. S., & Gersh, B. J. (2020). Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. Circulation. Arrhythmia and Electrophysiology, 13(6), e008688. https://doi.org/10.1161/CIRCEP.120.008688
Oren O, et al. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. Circ Arrhythm Electrophysiol. 2020;13(6):e008688. PubMed PMID: 32436730.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. AU - Oren,Ohad, AU - Yang,Eric H, AU - Gluckman,Ty J, AU - Michos,Erin D, AU - Blumenthal,Roger S, AU - Gersh,Bernard J, Y1 - 2020/05/21/ PY - 2020/5/22/pubmed PY - 2020/7/3/medline PY - 2020/5/22/entrez KW - COVID-19 KW - chloroquine KW - hydroxychloroquine KW - pandemic KW - trophozoites SP - e008688 EP - e008688 JF - Circulation. Arrhythmia and electrophysiology JO - Circ Arrhythm Electrophysiol VL - 13 IS - 6 SN - 1941-3084 UR - https://www.unboundmedicine.com/medline/citation/32436730/Use_of_Chloroquine_and_Hydroxychloroquine_in_COVID_19_and_Cardiovascular_Implications:_Understanding_Safety_Discrepancies_to_Improve_Interpretation_and_Design_of_Clinical_Trials_ DB - PRIME DP - Unbound Medicine ER -